OSELTAMIVIR

OSELTAMIVIR was reported 24445 times

OSELTAMIVIR is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ANTACID THERAPY 86 0.6615
1 SLEEP DISORDER THERAPY 120 0.6061
2 APPENDICOLITH 223 0.5762
3 ANALGESIC THERAPY 134 0.4174
4 DRUG THERAPY 129 0.3805
5 ANTICOAGULANT THERAPY 83 0.2923
6 CONGENITAL HIATUS HERNIA 58 0.2544
7 MALIGNANT MELANOMA STAGE 0 51 0.2440
8 PERIPROCTITIS 6 0.1875
9 ACNE INFANTILE 3 0.1765
10 ACUTE MACULAR OUTER RETINOPATHY 3 0.1579
11 BACTEROIDES INFECTION 35 0.1341
12 HEPATITIS INFECTIOUS MONONUCLEOSIS 12 0.1237
13 PLACENTAL NECROSIS 4 0.1212
14 AVIAN INFLUENZA 7 0.1094
15 PURPURA SENILE 10 0.0820
16 HYPERPHOSPHATAEMIA 161 0.0748
17 BLOOD PHOSPHORUS INCREASED 185 0.0677
18 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 52 0.0561
19 TARSAL TUNNEL SYNDROME 9 0.0409
20 NEONATAL PNEUMONIA 9 0.0383
21 APGAR SCORE ABNORMAL 4 0.0377
22 INFLUENZA A VIRUS TEST POSITIVE 15 0.0348
23 URINARY TRACT INFLAMMATION 12 0.0333
24 INFLUENZA VIRUS TEST POSITIVE 7 0.0332
25 SERUM AMYLOID A PROTEIN INCREASED 5 0.0323
26 PLACENTAL INFARCTION 7 0.0314
27 CHORDAE TENDINAE RUPTURE 3 0.0306
28 HETEROTAXIA 5 0.0299
29 NORMAL NEWBORN 161 0.0296
30 H1N1 INFLUENZA 40 0.0285
31 CONDUCTIVE DEAFNESS 9 0.0280
32 BLOOD URIC ACID INCREASED 152 0.0263
33 TOTAL LUNG CAPACITY DECREASED 41 0.0257
34 APPENDICITIS 230 0.0246
35 IRON DEFICIENCY 109 0.0242
36 GASTROINTESTINAL MUCORMYCOSIS 4 0.0240
37 AUTOINFLAMMATORY DISEASE 5 0.0236
38 NEUROPSYCHOLOGICAL SYMPTOMS 14 0.0232
39 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 117 0.0231
40 INTESTINAL MALROTATION 6 0.0227
41 JC VIRUS INFECTION 35 0.0219
42 MYASTHENIA GRAVIS 176 0.0218
43 DEXTROCARDIA 4 0.0213
44 HYPOPHOSPHATAEMIA 157 0.0212
45 AORTIC STENOSIS 73 0.0209
46 PLEURITIC PAIN 55 0.0199
47 BLOOD BRAIN BARRIER DEFECT 3 0.0197
48 VENTRICULAR FIBRILLATION 216 0.0194
49 IRIS ATROPHY 4 0.0193
50 PENILE BLISTER 4 0.0189
51 PRIMARY MYELOFIBROSIS 6 0.0186
52 BRONCHOPLEURAL FISTULA 7 0.0186
53 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 48 0.0180
54 CENTRAL VISION LOSS 4 0.0179
55 ACUTE MACULAR NEURORETINOPATHY 3 0.0175
56 LUNG OPACITY 46 0.0174
57 PULMONARY MUCORMYCOSIS 9 0.0170
58 RESPIRATORY SYMPTOM 45 0.0158
59 CARDIOGENIC SHOCK 227 0.0158
60 CONGESTIVE HEPATOPATHY 7 0.0156
61 GLOMERULONEPHRITIS MINIMAL LESION 11 0.0152
62 IDIOSYNCRATIC DRUG REACTION 14 0.0143
63 PNEUMONIA INFLUENZAL 17 0.0143
64 PYLORIC STENOSIS 12 0.0142
65 EXCESSIVE EYE BLINKING 20 0.0135
66 PATHOGEN RESISTANCE 121 0.0133
67 TRANSIENT TACHYPNOEA OF THE NEWBORN 5 0.0126
68 PNEUMONIA NECROTISING 8 0.0124
69 ACINETOBACTER INFECTION 13 0.0119
70 RIGHT ATRIAL DILATATION 6 0.0118
71 IMMUNOSUPPRESSANT DRUG LEVEL DECREASED 14 0.0117
72 PULMONARY VALVE STENOSIS CONGENITAL 5 0.0114
73 HEMIANOPIA 11 0.0111
74 TROPONIN INCREASED 84 0.0110
75 RESORPTION BONE INCREASED 9 0.0110
76 BACTERIAL INFECTION 200 0.0107
77 MULTIPLE ORGAN DYSFUNCTION SYNDROME 301 0.0106
78 LEGIONELLA INFECTION 6 0.0105
79 METAPNEUMOVIRUS INFECTION 8 0.0102
80 ENTEROCOLITIS HAEMORRHAGIC 15 0.0101
81 BENIGN PROSTATIC HYPERPLASIA 52 0.0101
82 OBSTRUCTIVE UROPATHY 4 0.0099
83 DYSBIOSIS 8 0.0097
84 BREATH SOUNDS ABNORMAL 47 0.0095
85 BONE DEMINERALISATION 10 0.0094
86 BLOOD CALCIUM INCREASED 82 0.0093
87 OBLITERATIVE BRONCHIOLITIS 12 0.0091
88 TRACHEOBRONCHITIS 7 0.0091
89 NEUROPSYCHIATRIC SYMPTOMS 8 0.0089
90 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 152 0.0089
91 APGAR SCORE LOW 11 0.0085
92 HYPERLIPIDAEMIA 98 0.0082
93 VESTIBULAR DISORDER 10 0.0082
94 ENCEPHALITIS HERPES 4 0.0081
95 HYPOFIBRINOGENAEMIA 8 0.0081
96 ASCITES 235 0.0080
97 SWOLLEN TONGUE 249 0.0080
98 INTESTINAL PSEUDO-OBSTRUCTION 7 0.0080
99 CYSTIC FIBROSIS RESPIRATORY INFECTION SUPPRESSION 7 0.0078
100 PORPHYRIA ACUTE 11 0.0077
101 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 8 0.0075
102 PLACENTAL DISORDER 7 0.0074
103 END STAGE RENAL DISEASE 135 0.0074
104 BRONCHOPULMONARY ASPERGILLOSIS 57 0.0073
105 NOSOCOMIAL INFECTION 16 0.0073
106 CANDIDA TEST POSITIVE 3 0.0072
107 CRYPTORCHISM 8 0.0071
108 FOETAL DISTRESS SYNDROME 15 0.0071
109 NEURALGIA 168 0.0069
110 DRUG-DISEASE INTERACTION 5 0.0068
111 PNEUMOCYSTIS JIROVECII INFECTION 8 0.0067
112 CEREBRAL HYPOPERFUSION 3 0.0064
113 PNEUMONIA MYCOPLASMAL 5 0.0063
114 ACUTE RESPIRATORY DISTRESS SYNDROME 110 0.0062
115 CARDIAC VALVE VEGETATION 3 0.0062
116 ULCER 98 0.0062
117 PREMATURE DELIVERY 96 0.0060
118 ASPERGILLUS INFECTION 39 0.0059
119 BLOOD TEST ABNORMAL 82 0.0058
120 GINGIVAL ERYTHEMA 5 0.0058
121 GOUT 103 0.0057
122 ANGIOEDEMA 250 0.0056
123 JARISCH-HERXHEIMER REACTION 4 0.0056
124 PNEUMONIA STREPTOCOCCAL 6 0.0055
125 DIFFERENTIATION SYNDROME 4 0.0054
126 LOW BIRTH WEIGHT BABY 42 0.0053
127 VERTIGO POSITIONAL 9 0.0051
128 PNEUMONIA VIRAL 16 0.0050
129 HYPONATRAEMIA 282 0.0050
130 ASPIRATION 54 0.0049
131 CEREBRAL ASPERGILLOSIS 3 0.0049
132 HYPERCHOLESTEROLAEMIA 47 0.0049
133 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 26 0.0048
134 FULL BLOOD COUNT ABNORMAL 50 0.0047
135 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 256 0.0047
136 PREGNANCY 93 0.0046
137 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 38 0.0046
138 ASPERGILLOSIS 6 0.0046
139 DRUG INTOLERANCE 438 0.0045
140 MICTURITION URGENCY 51 0.0045
141 STENOTROPHOMONAS INFECTION 6 0.0044
142 SCREAMING 28 0.0044
143 HYPERPARATHYROIDISM SECONDARY 11 0.0044
144 DIFFUSE ALVEOLAR DAMAGE 5 0.0043
145 METHAEMOGLOBINAEMIA 10 0.0043
146 DEATH NEONATAL 6 0.0043
147 DYSPHONIA 250 0.0043
148 ALCOHOL INTOLERANCE 3 0.0042
149 SWELLING FACE 273 0.0042
150 OLIGURIA 26 0.0042
151 RED BLOOD CELLS URINE POSITIVE 4 0.0041
152 PNEUMONIA PNEUMOCOCCAL 6 0.0040
153 EMPYEMA 8 0.0040
154 BRAIN STEM SYNDROME 3 0.0040
155 HEPATITIS CHOLESTATIC 24 0.0040
156 LUNG CONSOLIDATION 11 0.0039
157 NEPHROGENIC ANAEMIA 18 0.0039
158 PREMATURE RUPTURE OF MEMBRANES 9 0.0037
159 BLOOD CHOLESTEROL INCREASED 174 0.0037
160 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 191 0.0037
161 HYPERCAPNIA 11 0.0036
162 RALES 21 0.0036
163 DRUG EXPOSURE DURING PREGNANCY 121 0.0036
164 PO2 DECREASED 4 0.0035
165 COMPARTMENT SYNDROME 9 0.0034
166 SYSTEMIC MYCOSIS 4 0.0034
167 BRONCHIECTASIS 23 0.0034
168 NEUTROPENIC COLITIS 7 0.0034
169 TOXIC EPIDERMAL NECROLYSIS 51 0.0034
170 FOETAL DEATH 17 0.0033
171 TOOTH EROSION 4 0.0033
172 PNEUMONIA KLEBSIELLA 6 0.0033
173 NO ADVERSE EVENT 585 0.0032
174 TALIPES 10 0.0032
175 VENTRICULAR SEPTAL DEFECT 18 0.0031
176 ANTINUCLEAR ANTIBODY INCREASED 3 0.0031
177 BLOOD CHLORIDE DECREASED 8 0.0031
178 GESTATIONAL HYPERTENSION 4 0.0031
179 INFLUENZA 345 0.0031
180 PNEUMONIA CYTOMEGALOVIRAL 6 0.0031
181 CYTOMEGALOVIRUS CHORIORETINITIS 6 0.0031
182 ABDOMINAL WALL HAEMATOMA 6 0.0031
183 DRUG CLEARANCE DECREASED 4 0.0031
184 PREMATURE BABY 90 0.0030
185 LIVE BIRTH 25 0.0030
186 ENTEROBACTER INFECTION 5 0.0030
187 REBOUND ACID HYPERSECRETION 9 0.0030
188 THROMBOPHLEBITIS SUPERFICIAL 9 0.0030
189 COLITIS ISCHAEMIC 20 0.0030
190 MATERNAL EXPOSURE TIMING UNSPECIFIED 11 0.0029
191 LYMPHOPENIA 41 0.0029
192 STILLBIRTH 14 0.0029
193 TRANSAMINASES INCREASED 63 0.0028
194 ACUTE PSYCHOSIS 7 0.0028
195 SEPSIS 310 0.0028
196 NOCARDIOSIS 7 0.0027
197 CARDIAC AMYLOIDOSIS 3 0.0027
198 DRUG RESISTANCE 70 0.0027
199 GRAFT VERSUS HOST DISEASE IN SKIN 6 0.0027
200 DISORGANISED SPEECH 5 0.0027
201 BLOOD CREATINE INCREASED 12 0.0027
202 MUCORMYCOSIS 7 0.0027
203 CAESAREAN SECTION 31 0.0027
204 VASCULAR DEVICE INFECTION 12 0.0026
205 JAUNDICE NEONATAL 5 0.0026
206 HYPOPROTEINAEMIA 5 0.0026
207 BLOOD FIBRINOGEN DECREASED 3 0.0026
208 PARAINFLUENZAE VIRUS INFECTION 4 0.0026
209 HYPERLACTACIDAEMIA 7 0.0026
210 PNEUMONIA PSEUDOMONAL 4 0.0026
211 FOETAL EXPOSURE DURING PREGNANCY 211 0.0026
212 SLEEP DISORDER 181 0.0026
213 CONCOMITANT DISEASE PROGRESSION 5 0.0026
214 IRIDOCYCLITIS 8 0.0025
215 HISTOPLASMOSIS DISSEMINATED 4 0.0025
216 PATENT DUCTUS ARTERIOSUS 10 0.0025
217 COCCIDIOIDOMYCOSIS 3 0.0025
218 TACHYPNOEA 34 0.0025
219 HYPOXIA 88 0.0025
220 ABDOMINAL DISTENSION 260 0.0025
221 PREMATURE LABOUR 14 0.0025
222 LOWER RESPIRATORY TRACT INFECTION 112 0.0025
223 RESPIRATORY ALKALOSIS 4 0.0025
224 GENERAL PHYSICAL HEALTH DETERIORATION 283 0.0024
225 ORGANISING PNEUMONIA 12 0.0024
226 MITRAL VALVE PROLAPSE 4 0.0024
227 DIABETES MELLITUS 183 0.0024
228 ATRIAL SEPTAL DEFECT 20 0.0024
229 JOINT INJURY 51 0.0024
230 BREECH PRESENTATION 3 0.0024
231 BRADYCARDIA 126 0.0024
232 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 5 0.0023
233 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 18 0.0023
234 RHINOVIRUS INFECTION 9 0.0023
235 RESPIRATORY SYNCYTIAL VIRUS INFECTION 20 0.0023
236 DRY MOUTH 185 0.0023
237 SINUS BRADYCARDIA 22 0.0023
238 RETROPERITONEAL HAEMATOMA 5 0.0023
239 THROMBOSIS 182 0.0023
240 RESPIRATORY DISTRESS 62 0.0022
241 CHOLESTATIC LIVER INJURY 5 0.0022
242 ANHEDONIA 59 0.0022
243 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 38 0.0022
244 OFF LABEL USE 1906 0.0022
245 VIRAL MUTATION IDENTIFIED 8 0.0022
246 CLOSTRIDIUM DIFFICILE COLITIS 23 0.0022
247 LOBAR PNEUMONIA 4 0.0022
248 MATERNAL EXPOSURE DURING PREGNANCY 190 0.0021
249 HYPERPYREXIA 9 0.0021
250 PULMONARY EMBOLISM 202 0.0021
251 SPUTUM DISCOLOURED 20 0.0021
252 PSEUDOMONAS INFECTION 18 0.0021
253 PNEUMONIA BACTERIAL 19 0.0021
254 ENTEROCOCCAL INFECTION 10 0.0021
255 ADENOVIRUS INFECTION 6 0.0021
256 HAEMOTHORAX 6 0.0021
257 VIRAL LOAD INCREASED 8 0.0021
258 PULMONARY HAEMORRHAGE 16 0.0020
259 TORSADE DE POINTES 16 0.0020
260 INTENTIONAL PRODUCT MISUSE 178 0.0020
261 STAPHYLOCOCCAL SEPSIS 10 0.0020
262 SWELLING 189 0.0020
263 ATYPICAL PNEUMONIA 6 0.0020
264 CYSTIC FIBROSIS 11 0.0020
265 ASPARTATE AMINOTRANSFERASE ABNORMAL 3 0.0020
266 FIBRIN D DIMER INCREASED 7 0.0020
267 CONJUNCTIVAL HYPERAEMIA 7 0.0020
268 ASPARTATE AMINOTRANSFERASE INCREASED 104 0.0020
269 ANTICOAGULATION DRUG LEVEL ABOVE THERAPEUTIC 3 0.0020
270 LIVER FUNCTION TEST INCREASED 42 0.0020
271 PHLEBITIS 10 0.0020
272 MULTIPLE-DRUG RESISTANCE 6 0.0019
273 DELIRIUM 67 0.0019
274 DRUG-INDUCED LIVER INJURY 60 0.0019
275 PRE-ECLAMPSIA 9 0.0019
276 RESPIRATORY FAILURE 138 0.0019
277 PNEUMOCYSTIS JIROVECII PNEUMONIA 19 0.0019
278 PHARYNGEAL ERYTHEMA 4 0.0019
279 STUPOR 6 0.0019
280 STAPHYLOCOCCAL BACTERAEMIA 8 0.0018
281 HYPOGAMMAGLOBULINAEMIA 12 0.0018
282 BLOOD CREATININE INCREASED 119 0.0018
283 EXPOSURE DURING PREGNANCY 113 0.0018
284 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 6 0.0018
285 OTITIS MEDIA 6 0.0018
286 CYTOMEGALOVIRUS INFECTION REACTIVATION 8 0.0018
287 ELECTROCARDIOGRAM T WAVE INVERSION 4 0.0018
288 PEPTIC ULCER 6 0.0018
289 HYPERNATRAEMIA 9 0.0018
290 STEVENS-JOHNSON SYNDROME 40 0.0018
291 LIVER INJURY 44 0.0018
292 PULMONARY ALVEOLAR HAEMORRHAGE 10 0.0018
293 COVID-19 PNEUMONIA 21 0.0018
294 CHRONIC KIDNEY DISEASE 135 0.0018
295 COMPLICATIONS OF TRANSPLANTED KIDNEY 4 0.0018
296 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 45 0.0017
297 CYTOMEGALOVIRUS COLITIS 4 0.0017
298 PERIORBITAL OEDEMA 9 0.0017
299 CARDIOVASCULAR DISORDER 44 0.0017
300 MATERNAL DRUGS AFFECTING FOETUS 13 0.0017
301 TRANSIENT ISCHAEMIC ATTACK 57 0.0017
302 UPPER RESPIRATORY TRACT INFECTION 78 0.0017
303 EJECTION FRACTION DECREASED 26 0.0017
304 LONG QT SYNDROME 4 0.0017
305 CHOLESTASIS 32 0.0017
306 SLEEP TERROR 7 0.0017
307 HALLUCINATION, VISUAL 35 0.0017
308 SEPTIC SHOCK 72 0.0017
309 RASH VESICULAR 8 0.0017
310 CORONARY ARTERY DISEASE 50 0.0016
311 NEUTROPENIA 224 0.0016
312 BLOOD PHOSPHORUS DECREASED 6 0.0016
313 BRONCHITIS CHRONIC 4 0.0016
314 CHEST X-RAY ABNORMAL 5 0.0016
315 OBSTRUCTIVE AIRWAYS DISORDER 18 0.0016
316 ACUTE RESPIRATORY FAILURE 31 0.0016
317 TACHYARRHYTHMIA 4 0.0016
318 PULMONARY FUNCTION TEST DECREASED 7 0.0016
319 ENCEPHALITIS 11 0.0016
320 GINGIVAL SWELLING 7 0.0016
321 DERMATOMYOSITIS 4 0.0016
322 HAEMODYNAMIC INSTABILITY 12 0.0016
323 HYPERSENSITIVITY 291 0.0016
324 ELECTROCARDIOGRAM QT PROLONGED 55 0.0015
325 IMMUNE THROMBOCYTOPENIA 7 0.0015
326 RESPIRATORY ACIDOSIS 6 0.0015
327 NEPHROPATHY TOXIC 17 0.0015
328 PNEUMOTHORAX 24 0.0015
329 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 5 0.0015
330 CYSTITIS HAEMORRHAGIC 6 0.0015
331 BK VIRUS INFECTION 5 0.0015
332 LUNG INFILTRATION 13 0.0015
333 HAEMOPTYSIS 41 0.0015
334 PRODUCT USE IN UNAPPROVED INDICATION 360 0.0015
335 ALANINE AMINOTRANSFERASE ABNORMAL 3 0.0014
336 DISSEMINATED INTRAVASCULAR COAGULATION 20 0.0014
337 SMALL FOR DATES BABY 7 0.0014
338 PULMONARY MASS 21 0.0014
339 ABDOMINAL PAIN 326 0.0014
340 NEUTROPENIC SEPSIS 10 0.0014
341 HYPERAMMONAEMIA 7 0.0014
342 ERYTHEMA MULTIFORME 13 0.0014
343 GRAFT VERSUS HOST DISEASE 10 0.0014
344 BLOOD ALBUMIN DECREASED 11 0.0014
345 ELECTROLYTE IMBALANCE 16 0.0014
346 CACHEXIA 7 0.0014
347 PULMONARY FIBROSIS 26 0.0014
348 SHOCK HAEMORRHAGIC 11 0.0013
349 CYTOMEGALOVIRUS VIRAEMIA 6 0.0013
350 PLEURAL EFFUSION 82 0.0013
351 ATELECTASIS 13 0.0013
352 LIVER DISORDER 59 0.0013
353 CEREBROVASCULAR DISORDER 4 0.0013
354 RENAL TUBULAR NECROSIS 13 0.0013
355 ECONOMIC PROBLEM 20 0.0013
356 CONDITION AGGRAVATED 399 0.0013
357 BUNDLE BRANCH BLOCK RIGHT 6 0.0013
358 ANAEMIA 249 0.0013
359 BLOOD PRESSURE DIASTOLIC INCREASED 6 0.0013
360 EPSTEIN-BARR VIRUS INFECTION 8 0.0013
361 ANURIA 11 0.0013
362 MULTI-ORGAN FAILURE 22 0.0013
363 COAGULOPATHY 21 0.0013
364 TRICUSPID VALVE INCOMPETENCE 10 0.0013
365 PNEUMONIA 407 0.0013
366 BLOOD COUNT ABNORMAL 19 0.0013
367 OSTEOPENIA 19 0.0013
368 AZOTAEMIA 5 0.0013
369 TUMOUR LYSIS SYNDROME 11 0.0012
370 C-REACTIVE PROTEIN ABNORMAL 8 0.0012
371 RESPIRATORY RATE INCREASED 11 0.0012
372 TRIGGER FINGER 5 0.0012
373 CORONAVIRUS INFECTION 8 0.0012
374 AORTIC DISSECTION 5 0.0012
375 LUNG DISORDER 59 0.0012
376 STRESS CARDIOMYOPATHY 7 0.0012
377 HEPATOCELLULAR INJURY 17 0.0012
378 CONSTIPATION 261 0.0012
379 KLEBSIELLA INFECTION 6 0.0012
380 ABNORMAL BEHAVIOUR 47 0.0012
381 BRAIN ABSCESS 3 0.0012
382 HYPOTHERMIA 12 0.0012
383 HAEMATEMESIS 30 0.0012
384 SHOCK 27 0.0012
385 ENDOCARDITIS 6 0.0012
386 INTERNATIONAL NORMALISED RATIO INCREASED 33 0.0012
387 SOMNOLENCE 233 0.0012
388 ACUTE KIDNEY INJURY 176 0.0011
389 SUPRAVENTRICULAR TACHYCARDIA 11 0.0011
390 RENAL INJURY 34 0.0011
391 BLOOD LACTIC ACID INCREASED 6 0.0011
392 HAEMORRHAGE INTRACRANIAL 17 0.0011
393 HALLUCINATION 85 0.0011
394 RHINITIS ALLERGIC 5 0.0011
395 CHEILITIS 6 0.0011
396 SUSPECTED OFF LABEL USE 5 0.0011
397 CLONUS 3 0.0011
398 HEPATIC FAILURE 33 0.0011
399 THROMBOCYTOSIS 4 0.0011
400 FEBRILE NEUTROPENIA 72 0.0011
401 IRON DEFICIENCY ANAEMIA 10 0.0011
402 LEUKOPENIA 54 0.0011
403 BLOOD BILIRUBIN INCREASED 29 0.0011
404 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 8 0.0011
405 ANTIPSYCHOTIC DRUG LEVEL INCREASED 3 0.0011
406 VOMITING 501 0.0011
407 SPINAL COLUMN STENOSIS 5 0.0011
408 NEUROLOGICAL SYMPTOM 6 0.0010
409 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 10 0.0010
410 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 4 0.0010
411 DRUG LEVEL INCREASED 17 0.0010
412 ALANINE AMINOTRANSFERASE INCREASED 63 0.0010
413 MUSCULOSKELETAL STIFFNESS 89 0.0010
414 PNEUMONIA FUNGAL 4 0.0010
415 CREATININE RENAL CLEARANCE DECREASED 4 0.0010
416 ASTHMA 112 0.0010
417 PERIPHERAL ISCHAEMIA 4 0.0010
418 RENAL FAILURE 130 0.0010
419 ANAPHYLACTOID REACTION 4 0.0010
420 LUNG INFECTION 15 0.0010
421 DRUG INTERACTION 153 0.0010
422 CYTOMEGALOVIRUS INFECTION 16 0.0010
423 BLOOD SODIUM DECREASED 18 0.0010
424 HALLUCINATIONS, MIXED 4 0.0010
425 THROMBOCYTOPENIA 106 0.0009
426 LOWER GASTROINTESTINAL HAEMORRHAGE 7 0.0009
427 VASCULITIS 11 0.0009
428 HALLUCINATION, AUDITORY 15 0.0009
429 HEPATIC FUNCTION ABNORMAL 35 0.0009
430 GINGIVITIS 5 0.0009
431 DIVERTICULUM INTESTINAL 4 0.0009
432 BODY TEMPERATURE DECREASED 9 0.0009
433 BRONCHOSPASM 13 0.0009
434 HYPOTONIA 9 0.0009
435 DELUSION 14 0.0009
436 CARDIAC FAILURE ACUTE 6 0.0009
437 ATRIOVENTRICULAR BLOCK COMPLETE 6 0.0009
438 TOXIC SKIN ERUPTION 9 0.0009
439 HAEMOLYTIC ANAEMIA 8 0.0009
440 UPPER GASTROINTESTINAL HAEMORRHAGE 15 0.0009
441 INTENTIONAL PRODUCT USE ISSUE 78 0.0009
442 LEUKOCYTOSIS 16 0.0009
443 GINGIVAL PAIN 7 0.0009
444 AUTOIMMUNE HAEMOLYTIC ANAEMIA 3 0.0009
445 LOCALISED OEDEMA 4 0.0009
446 HYPERVENTILATION 5 0.0009
447 BONE DENSITY DECREASED 27 0.0009
448 RIGHT VENTRICULAR FAILURE 6 0.0009
449 HEPATOTOXICITY 19 0.0009
450 ABORTION INDUCED 8 0.0008
451 PAIN IN JAW 24 0.0008
452 ACUTE CORONARY SYNDROME 7 0.0008
453 PNEUMONITIS 23 0.0008
454 PLATELET COUNT INCREASED 11 0.0008
455 GESTATIONAL DIABETES 4 0.0008
456 RHABDOMYOLYSIS 35 0.0008
457 PYREXIA 289 0.0008
458 IMPAIRED QUALITY OF LIFE 12 0.0008
459 CLOSTRIDIUM DIFFICILE INFECTION 18 0.0008
460 FOETAL GROWTH RESTRICTION 5 0.0008
461 QUALITY OF LIFE DECREASED 11 0.0008
462 SKIN FISSURES 16 0.0008
463 ORAL DISORDER 6 0.0008
464 BLINDNESS TRANSIENT 6 0.0008
465 AMYLASE INCREASED 3 0.0008
466 CARDIAC DYSFUNCTION 3 0.0008
467 BLOOD ALKALINE PHOSPHATASE INCREASED 20 0.0008
468 ACUTE HEPATIC FAILURE 11 0.0008
469 MIDDLE INSOMNIA 15 0.0008
470 LACTIC ACIDOSIS 26 0.0008
471 PROTEIN URINE PRESENT 4 0.0008
472 TUBULOINTERSTITIAL NEPHRITIS 15 0.0008
473 DEEP VEIN THROMBOSIS 52 0.0008
474 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 38 0.0008
475 COMMUNICATION DISORDER 3 0.0008
476 SEROTONIN SYNDROME 15 0.0008
477 OEDEMA PERIPHERAL 95 0.0008
478 SINUS TACHYCARDIA 11 0.0008
479 INCOHERENT 5 0.0008
480 HYPERBILIRUBINAEMIA 8 0.0008
481 APLASTIC ANAEMIA 4 0.0008
482 CYANOSIS 12 0.0008
483 BACTERAEMIA 9 0.0008
484 SERUM FERRITIN INCREASED 4 0.0008
485 BLOOD LACTATE DEHYDROGENASE INCREASED 12 0.0008
486 FLUID OVERLOAD 11 0.0008
487 RENAL CYST 6 0.0008
488 GASTROENTERITIS 11 0.0008
489 WRIST FRACTURE 9 0.0008
490 DECREASED ACTIVITY 8 0.0007
491 HYPOCALCAEMIA 14 0.0007
492 DECUBITUS ULCER 6 0.0007
493 SKIN LACERATION 8 0.0007
494 HEADACHE 461 0.0007
495 POLYURIA 6 0.0007
496 MULTIPLE FRACTURES 12 0.0007
497 OSTEOPOROSIS 30 0.0007
498 INTESTINAL ISCHAEMIA 4 0.0007
499 GASTROINTESTINAL DISORDER 65 0.0007
500 NIGHTMARE 25 0.0007
501 MENTAL STATUS CHANGES 20 0.0007
502 HYPERTRANSAMINASAEMIA 5 0.0007
503 THROMBOTIC MICROANGIOPATHY 7 0.0007
504 VITAMIN D DEFICIENCY 7 0.0007
505 DERMATITIS ALLERGIC 9 0.0007
506 PHARYNGEAL SWELLING 7 0.0007
507 SKIN INFECTION 8 0.0007
508 ATTENTION DEFICIT HYPERACTIVITY DISORDER 3 0.0007
509 THERAPY NON-RESPONDER 32 0.0007
510 PAPULE 5 0.0007
511 CHOLECYSTITIS ACUTE 4 0.0007
512 HEPATIC CYTOLYSIS 9 0.0007
513 PARANOIA 12 0.0007
514 ATRIOVENTRICULAR BLOCK FIRST DEGREE 3 0.0007
515 NEUTROPHIL COUNT DECREASED 28 0.0007
516 SPINAL OSTEOARTHRITIS 6 0.0007
517 SPLENOMEGALY 8 0.0007
518 TOOTH INFECTION 9 0.0007
519 DISORIENTATION 27 0.0007
520 HYPERTENSION 144 0.0007
521 DRUG ERUPTION 12 0.0007
522 VENTRICULAR EXTRASYSTOLES 7 0.0007
523 ABORTION SPONTANEOUS 27 0.0007
524 PULMONARY HYPERTENSION 14 0.0007
525 PETECHIAE 7 0.0007
526 RESPIRATORY DISORDER 20 0.0007
527 STAPHYLOCOCCAL INFECTION 22 0.0007
528 DERMATITIS ATOPIC 35 0.0007
529 PSYCHOMOTOR HYPERACTIVITY 11 0.0007
530 RENAL PAIN 7 0.0007
531 IMPAIRED GASTRIC EMPTYING 9 0.0007
532 UNRESPONSIVE TO STIMULI 17 0.0007
533 PERICARDIAL EFFUSION 15 0.0006
534 CYTOKINE RELEASE SYNDROME 13 0.0006
535 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 4 0.0006
536 HAEMOLYSIS 5 0.0006
537 PHARYNGITIS 8 0.0006
538 PSYCHOTIC DISORDER 19 0.0006
539 HYPOALBUMINAEMIA 5 0.0006
540 FLANK PAIN 6 0.0006
541 SEASONAL ALLERGY 9 0.0006
542 INFUSION SITE SWELLING 4 0.0006
543 DRUG INEFFECTIVE 829 0.0006
544 NAUSEA 497 0.0006
545 METABOLIC ACIDOSIS 20 0.0006
546 MENTAL DISORDER 27 0.0006
547 MITRAL VALVE INCOMPETENCE 7 0.0006
548 HEPATITIS ACUTE 4 0.0006
549 HERPES SIMPLEX 4 0.0006
550 PANCYTOPENIA 34 0.0006
551 TOOTHACHE 11 0.0006
552 ORAL CANDIDIASIS 8 0.0006
553 GENERALISED TONIC-CLONIC SEIZURE 10 0.0006
554 EOSINOPHIL COUNT INCREASED 5 0.0006
555 HAEMODIALYSIS 5 0.0006
556 INFUSION SITE ERYTHEMA 5 0.0006
557 PRODUCT TASTE ABNORMAL 8 0.0006
558 WHITE BLOOD CELL COUNT DECREASED 64 0.0006
559 PRODUCT LABEL ISSUE 4 0.0006
560 SEIZURE 68 0.0006
561 COVID-19 103 0.0006
562 DYSPNOEA 332 0.0006
563 POLYNEUROPATHY 7 0.0006
564 THERAPY CESSATION 30 0.0006
565 GASTROOESOPHAGEAL REFLUX DISEASE 47 0.0006
566 CEREBRAL ISCHAEMIA 3 0.0006
567 CARDIAC ARREST 48 0.0006
568 RESPIRATION ABNORMAL 4 0.0006
569 ANAPHYLACTIC REACTION 32 0.0006
570 EMOTIONAL DISTRESS 70 0.0006
571 RESPIRATORY TRACT INFECTION 15 0.0006
572 APHONIA 8 0.0006
573 AGITATION 42 0.0006
574 PRODUCTIVE COUGH 27 0.0006
575 GENERALISED OEDEMA 7 0.0006
576 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 5 0.0006
577 RASH ERYTHEMATOUS 27 0.0006
578 ORAL HERPES 11 0.0006
579 AGEUSIA 14 0.0006
580 COMPRESSION FRACTURE 3 0.0006
581 AGGRESSION 28 0.0006
582 PULMONARY OEDEMA 25 0.0006
583 BRONCHITIS 41 0.0006
584 VISUAL FIELD DEFECT 4 0.0006
585 OXYGEN SATURATION DECREASED 31 0.0006
586 MANIA 9 0.0005
587 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 16 0.0005
588 MELAENA 12 0.0005
589 DENTAL CARIES 6 0.0005
590 PSYCHIATRIC SYMPTOM 4 0.0005
591 NERVE COMPRESSION 5 0.0005
592 HIATUS HERNIA 7 0.0005
593 WHEEZING 32 0.0005
594 THINKING ABNORMAL 10 0.0005
595 STATUS EPILEPTICUS 6 0.0005
596 TENDON PAIN 4 0.0005
597 CARDIO-RESPIRATORY ARREST 22 0.0005
598 CONFUSIONAL STATE 85 0.0005
599 DERMATITIS 11 0.0005
600 MYOCARDITIS 6 0.0005
601 CRYING 19 0.0005
602 LIPASE INCREASED 4 0.0005
603 GLAUCOMA 10 0.0005
604 ABDOMINAL PAIN LOWER 13 0.0005
605 PANCREATITIS 27 0.0005
606 FUNGAL INFECTION 17 0.0005
607 ELECTROCARDIOGRAM ABNORMAL 4 0.0005
608 PRODUCT ADMINISTRATION INTERRUPTED 4 0.0005
609 LYMPHOCYTE COUNT DECREASED 9 0.0005
610 TACHYCARDIA 45 0.0005
611 DYSARTHRIA 19 0.0005
612 CHOLECYSTITIS 6 0.0005
613 INFECTION 72 0.0005
614 SEDATION 13 0.0005
615 GAMMA-GLUTAMYLTRANSFERASE INCREASED 11 0.0005
616 TOOTH ABSCESS 5 0.0005
617 NEUTROPHIL COUNT INCREASED 5 0.0005
618 RENAL IMPAIRMENT 41 0.0005
619 ESCHERICHIA INFECTION 4 0.0005
620 UPPER-AIRWAY COUGH SYNDROME 4 0.0005
621 FEAR 13 0.0005
622 PULMONARY ARTERIAL HYPERTENSION 7 0.0005
623 TREMOR 80 0.0005
624 PERICARDITIS 8 0.0005
625 CANDIDA INFECTION 8 0.0005
626 IMMUNODEFICIENCY 7 0.0005
627 C-REACTIVE PROTEIN INCREASED 17 0.0005
628 GASTROINTESTINAL HAEMORRHAGE 39 0.0005
629 HYPERGLYCAEMIA 17 0.0005
630 DISEASE PROGRESSION 55 0.0005
631 RESTLESSNESS 17 0.0005
632 CARDIAC MURMUR 4 0.0005
633 PYELONEPHRITIS 4 0.0005
634 SKIN SWELLING 4 0.0005
635 BIPOLAR DISORDER 5 0.0005
636 NODULE 6 0.0005
637 PRODUCT DOSE OMISSION IN ERROR 13 0.0005
638 URINE OUTPUT DECREASED 4 0.0005
639 CELLULITIS 23 0.0005
640 PULMONARY CONGESTION 6 0.0005
641 GRIP STRENGTH DECREASED 4 0.0005
642 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 32 0.0004
643 CARDIOTOXICITY 4 0.0004
644 OSTEOARTHRITIS 19 0.0004
645 ENCEPHALOPATHY 11 0.0004
646 COUGH 124 0.0004
647 BODY TEMPERATURE INCREASED 9 0.0004
648 ACUTE MYOCARDIAL INFARCTION 13 0.0004
649 SCIATICA 7 0.0004
650 RETINAL DETACHMENT 4 0.0004
651 AUTOIMMUNE HEPATITIS 3 0.0004
652 ATRIAL FIBRILLATION 42 0.0004
653 HEPATIC STEATOSIS 8 0.0004
654 HEPATIC ENCEPHALOPATHY 4 0.0004
655 NEPHROPATHY 4 0.0004
656 DIARRHOEA HAEMORRHAGIC 4 0.0004
657 RASH 186 0.0004
658 HEPATIC ENZYME INCREASED 29 0.0004
659 DIARRHOEA 274 0.0004
660 NEUROLEPTIC MALIGNANT SYNDROME 5 0.0004
661 PROTEINURIA 8 0.0004
662 FACE OEDEMA 7 0.0004
663 ANOSMIA 6 0.0004
664 PRODUCT DOSE OMISSION 27 0.0004
665 EAR INFECTION 11 0.0004
666 LIVER FUNCTION TEST ABNORMAL 12 0.0004
667 NOCTURIA 5 0.0004
668 PANIC ATTACK 15 0.0004
669 BLOOD PRESSURE SYSTOLIC INCREASED 8 0.0004
670 PLASMA CELL MYELOMA 16 0.0004
671 ANXIETY 116 0.0004
672 LABORATORY TEST ABNORMAL 12 0.0004
673 CARDIOMYOPATHY 6 0.0004
674 CEREBRAL DISORDER 3 0.0004
675 ARTHROPOD BITE 3 0.0004
676 RASH MACULO-PAPULAR 9 0.0004
677 ORTHOSTATIC HYPOTENSION 7 0.0004
678 RENAL FAILURE ACUTE 17 0.0004
679 BRAIN INJURY 4 0.0004
680 CARDIAC FAILURE 32 0.0004
681 AORTIC ANEURYSM 3 0.0004
682 DRY THROAT 4 0.0004
683 ACIDOSIS 3 0.0004
684 MUSCLE TWITCHING 9 0.0004
685 CHEST PAIN 72 0.0004
686 ATRIOVENTRICULAR BLOCK 3 0.0004
687 COGNITIVE DISORDER 18 0.0004
688 ACUTE MYELOID LEUKAEMIA 6 0.0004
689 ABDOMINAL PAIN UPPER 79 0.0004
690 ARRHYTHMIA 18 0.0004
691 PRODUCT PRESCRIBING ERROR 9 0.0004
692 RESPIRATORY TRACT CONGESTION 6 0.0004
693 AGRANULOCYTOSIS 7 0.0004
694 ATRIAL FLUTTER 3 0.0004
695 INSOMNIA 100 0.0004
696 BLOOD DISORDER 3 0.0004
697 SINUSITIS 38 0.0004
698 PRODUCT DOSE OMISSION ISSUE 109 0.0004
699 BLOOD POTASSIUM INCREASED 6 0.0004
700 ALTERED STATE OF CONSCIOUSNESS 8 0.0004
701 FAECES DISCOLOURED 8 0.0004
702 PALLOR 10 0.0004
703 SLEEP APNOEA SYNDROME 7 0.0004
704 CHOLELITHIASIS 12 0.0004
705 VENTRICULAR TACHYCARDIA 6 0.0004
706 CONTRAINDICATED PRODUCT ADMINISTERED 11 0.0004
707 RESPIRATORY ARREST 10 0.0004
708 ABNORMAL DREAMS 10 0.0004
709 MYELOSUPPRESSION 13 0.0004
710 VIRAL INFECTION 12 0.0004
711 NERVE INJURY 4 0.0004
712 BLOOD UREA INCREASED 6 0.0004
713 MALNUTRITION 4 0.0004
714 INTESTINAL PERFORATION 4 0.0004
715 OCULAR DISCOMFORT 4 0.0004
716 BLOOD CALCIUM DECREASED 4 0.0004
717 DEPRESSED LEVEL OF CONSCIOUSNESS 14 0.0004
718 DEHYDRATION 47 0.0004
719 HYPOGLYCAEMIA 17 0.0004
720 ANAPHYLACTIC SHOCK 9 0.0003
721 RASH GENERALISED 9 0.0003
722 BLOOD CREATINE PHOSPHOKINASE INCREASED 10 0.0003
723 HYPOKALAEMIA 16 0.0003
724 INTESTINAL OBSTRUCTION 13 0.0003
725 EYELID OEDEMA 4 0.0003
726 RENAL DISORDER 16 0.0003
727 NEUROTOXICITY 6 0.0003
728 HYPERKALAEMIA 12 0.0003
729 BLOOD TRIGLYCERIDES INCREASED 6 0.0003
730 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 61 0.0003
731 ATAXIA 4 0.0003
732 NEUROPATHY PERIPHERAL 32 0.0003
733 CEREBRAL HAEMORRHAGE 12 0.0003
734 MUSCLE RIGIDITY 4 0.0003
735 GASTROENTERITIS VIRAL 6 0.0003
736 APHASIA 10 0.0003
737 INTERSTITIAL LUNG DISEASE 16 0.0003
738 LIP SWELLING 11 0.0003
739 SKIN DISORDER 11 0.0003
740 ADRENAL INSUFFICIENCY 4 0.0003
741 EATING DISORDER 7 0.0003
742 EPILEPSY 10 0.0003
743 GLOMERULAR FILTRATION RATE DECREASED 4 0.0003
744 DEPRESSION 74 0.0003
745 CONJUNCTIVITIS 6 0.0003
746 ANKLE FRACTURE 5 0.0003
747 PRODUCT PRESCRIBING ISSUE 7 0.0003
748 HAEMATURIA 11 0.0003
749 EPISTAXIS 24 0.0003
750 BLISTER 18 0.0003
751 DYSPNOEA EXERTIONAL 12 0.0003
752 COLITIS 12 0.0003
753 BLOOD URINE PRESENT 6 0.0003
754 HEAD INJURY 10 0.0003
755 INFLUENZA LIKE ILLNESS 26 0.0003
756 MUSCULOSKELETAL DISORDER 6 0.0003
757 COMA 15 0.0003
758 PAIN 193 0.0003
759 HYPOTENSION 63 0.0003
760 OROPHARYNGEAL PAIN 29 0.0003
761 HEPATITIS 8 0.0003
762 ORAL PAIN 7 0.0003
763 THROAT IRRITATION 14 0.0003
764 DISCOMFORT 19 0.0003
765 LYMPHADENOPATHY 11 0.0003
766 INFUSION SITE PAIN 4 0.0003
767 EAR PAIN 6 0.0003
768 ASTHENIA 116 0.0003
769 URINARY TRACT INFECTION 52 0.0003
770 METASTASES TO BONE 5 0.0003
771 IMMUNE SYSTEM DISORDER 4 0.0003
772 BACK PAIN 70 0.0003
773 VAGINAL HAEMORRHAGE 13 0.0003
774 BLOOD POTASSIUM DECREASED 9 0.0003
775 SKIN EXFOLIATION 25 0.0003
776 FEEDING DISORDER 6 0.0003
777 ANGER 10 0.0003
778 PSORIATIC ARTHROPATHY 12 0.0003
779 LETHARGY 17 0.0003
780 LIMB INJURY 8 0.0003
781 RHINORRHOEA 19 0.0003
782 RIB FRACTURE 6 0.0003
783 PRESYNCOPE 7 0.0003
784 WHITE BLOOD CELL COUNT INCREASED 11 0.0003
785 CARPAL TUNNEL SYNDROME 4 0.0003
786 MOUTH ULCERATION 6 0.0003
787 DIALYSIS 4 0.0003
788 PLATELET COUNT DECREASED 30 0.0003
789 IRRITABLE BOWEL SYNDROME 6 0.0003
790 RED BLOOD CELL COUNT DECREASED 8 0.0003
791 POOR QUALITY SLEEP 6 0.0003
792 SYNOVITIS 5 0.0003
793 RASH PRURITIC 15 0.0003
794 OEDEMA 15 0.0003
795 INTERVERTEBRAL DISC PROTRUSION 6 0.0003
796 ACCIDENTAL OVERDOSE 10 0.0003
797 PARAESTHESIA 43 0.0003
798 SKIN ULCER 7 0.0003
799 SKIN HAEMORRHAGE 4 0.0003
800 RASH PAPULAR 6 0.0003
801 HYPOAESTHESIA 40 0.0003
802 PRODUCT USE ISSUE 50 0.0003
803 CHROMATURIA 6 0.0003
804 MYALGIA 45 0.0003
805 INCREASED APPETITE 5 0.0003
806 PAIN OF SKIN 7 0.0003
807 DEVICE RELATED INFECTION 4 0.0003
808 HERNIA 5 0.0003
809 TENDONITIS 4 0.0003
810 DEATH 221 0.0003
811 THERAPY PARTIAL RESPONDER 4 0.0003
812 BRAIN FOG 4 0.0003
813 CHEST DISCOMFORT 26 0.0003
814 HAEMATOCRIT DECREASED 5 0.0003
815 SPINAL FRACTURE 5 0.0002
816 PRODUCT ADMINISTRATION ERROR 5 0.0002
817 THERAPEUTIC RESPONSE DECREASED 15 0.0002
818 HOSPITALISATION 38 0.0002
819 PRURITUS 95 0.0002
820 EXTRA DOSE ADMINISTERED 10 0.0002
821 PERIPHERAL SWELLING 38 0.0002
822 DEPRESSED MOOD 13 0.0002
823 DECREASED APPETITE 57 0.0002
824 URTICARIA 41 0.0002
825 TOOTH LOSS 5 0.0002
826 SUICIDAL IDEATION 22 0.0002
827 POLLAKIURIA 10 0.0002
828 DYSSTASIA 7 0.0002
829 GAIT INABILITY 8 0.0002
830 SURGERY 14 0.0002
831 THERAPY INTERRUPTED 17 0.0002
832 BRAIN OEDEMA 3 0.0002
833 FATIGUE 183 0.0002
834 RETCHING 5 0.0002
835 ILLNESS 24 0.0002
836 DISEASE RECURRENCE 11 0.0002
837 DIPLOPIA 6 0.0002
838 STOMATITIS 14 0.0002
839 ECZEMA 12 0.0002
840 DYSGEUSIA 17 0.0002
841 BEDRIDDEN 3 0.0002
842 DIZZINESS 113 0.0002
843 LIMB DISCOMFORT 7 0.0002
844 HEART RATE INCREASED 22 0.0002
845 THROAT TIGHTNESS 6 0.0002
846 NASAL CONGESTION 13 0.0002
847 OSTEOMYELITIS 4 0.0002
848 CYSTITIS 7 0.0002
849 TOXICITY TO VARIOUS AGENTS 37 0.0002
850 SKIN LESION 6 0.0002
851 DYSURIA 8 0.0002
852 EYE SWELLING 8 0.0002
853 NECK PAIN 12 0.0002
854 DEMENTIA 6 0.0002
855 GASTRIC ULCER 4 0.0002
856 MUSCULOSKELETAL PAIN 11 0.0002
857 HYPERHIDROSIS 27 0.0002
858 HERPES ZOSTER 12 0.0002
859 LOWER LIMB FRACTURE 4 0.0002
860 PSORIASIS 27 0.0002
861 HAEMORRHOIDS 4 0.0002
862 COMPLETED SUICIDE 17 0.0002
863 DYSPEPSIA 20 0.0002
864 BLOOD PRESSURE INCREASED 31 0.0002
865 SINUS DISORDER 4 0.0002
866 BLOOD PRESSURE ABNORMAL 4 0.0002
867 DYSPHAGIA 19 0.0002
868 PNEUMONIA ASPIRATION 5 0.0002
869 BONE LOSS 3 0.0002
870 ERYTHEMA 41 0.0002
871 MALAISE 87 0.0002
872 INTENTIONAL SELF-INJURY 4 0.0002
873 MEDICATION ERROR 11 0.0002
874 ABDOMINAL DISCOMFORT 33 0.0002
875 FEELING HOT 12 0.0002
876 BLOOD PRESSURE DECREASED 13 0.0002
877 LOSS OF CONSCIOUSNESS 25 0.0002
878 PAIN IN EXTREMITY 57 0.0002
879 WEIGHT DECREASED 54 0.0002
880 TREATMENT FAILURE 16 0.0002
881 CONVULSION 11 0.0002
882 NERVOUS SYSTEM DISORDER 6 0.0002
883 MUCOSAL INFLAMMATION 5 0.0002
884 ARTHRITIS 15 0.0002
885 PALPITATIONS 22 0.0002
886 BONE PAIN 11 0.0002
887 CHILLS 22 0.0002
888 JAUNDICE 5 0.0002
889 DISTURBANCE IN ATTENTION 10 0.0002
890 HAEMOGLOBIN DECREASED 19 0.0002
891 PRODUCT DISPENSING ERROR 4 0.0002
892 EYE PAIN 10 0.0002
893 CIRCULATORY COLLAPSE 3 0.0002
894 MUSCULAR WEAKNESS 20 0.0002
895 ANGINA PECTORIS 5 0.0002
896 TINNITUS 8 0.0002
897 SKIN DISCOLOURATION 8 0.0002
898 HAEMORRHAGE 18 0.0002
899 SPEECH DISORDER 9 0.0002
900 COLD SWEAT 3 0.0002
901 SYNCOPE 17 0.0002
902 AMNESIA 11 0.0002
903 SYSTEMIC LUPUS ERYTHEMATOSUS 6 0.0002
904 URINARY INCONTINENCE 5 0.0002
905 FLUSHING 17 0.0002
906 MOBILITY DECREASED 12 0.0002
907 BLOOD GLUCOSE DECREASED 8 0.0002
908 IRRITABILITY 10 0.0002
909 ILL-DEFINED DISORDER 10 0.0002
910 FIBROMYALGIA 4 0.0002
911 CEREBRAL INFARCTION 4 0.0002
912 HAEMATOCHEZIA 9 0.0002
913 INJECTION SITE URTICARIA 4 0.0002
914 EXTRAPYRAMIDAL DISORDER 4 0.0002
915 RHEUMATOID ARTHRITIS 18 0.0002
916 HYPOTHYROIDISM 5 0.0002
917 HAEMATOMA 4 0.0002
918 CHOKING 3 0.0002
919 NEPHROLITHIASIS 7 0.0002
920 GASTRITIS 4 0.0002
921 NASOPHARYNGITIS 28 0.0002
922 EYE PRURITUS 5 0.0001
923 SUICIDE ATTEMPT 9 0.0001
924 FREQUENT BOWEL MOVEMENTS 4 0.0001
925 DYSKINESIA 6 0.0001
926 BONE MARROW FAILURE 3 0.0001
927 OCULAR HYPERAEMIA 7 0.0001
928 FALL 49 0.0001
929 MOOD ALTERED 4 0.0001
930 UNEVALUABLE EVENT 11 0.0001
931 ARTHRALGIA 60 0.0001
932 NEOPLASM PROGRESSION 5 0.0001
933 WOUND 4 0.0001
934 WEIGHT INCREASED 32 0.0001
935 HEART RATE DECREASED 5 0.0001
936 DRY SKIN 19 0.0001
937 FEELING ABNORMAL 34 0.0001
938 JOINT SWELLING 17 0.0001
939 INTENTIONAL DOSE OMISSION 4 0.0001
940 HYPERSOMNIA 4 0.0001
941 BALANCE DISORDER 12 0.0001
942 VISUAL IMPAIRMENT 17 0.0001
943 UNDERDOSE 10 0.0001
944 CONTUSION 13 0.0001
945 THERAPEUTIC RESPONSE UNEXPECTED 6 0.0001
946 DRUG DOSE OMISSION 22 0.0001
947 LACRIMATION INCREASED 4 0.0001
948 MULTIPLE SCLEROSIS RELAPSE 9 0.0001
949 MEMORY IMPAIRMENT 18 0.0001
950 INJECTION SITE REACTION 9 0.0001
951 CEREBROVASCULAR ACCIDENT 22 0.0001
952 EMOTIONAL DISORDER 4 0.0001
953 MUSCLE SPASMS 23 0.0001
954 VISION BLURRED 17 0.0001
955 BLINDNESS 5 0.0001
956 INFUSION RELATED REACTION 8 0.0001
957 THERAPEUTIC RESPONSE SHORTENED 4 0.0001
958 GAIT DISTURBANCE 23 0.0001
959 CATARACT 7 0.0001
960 GASTRIC DISORDER 4 0.0001
961 RECTAL HAEMORRHAGE 5 0.0001
962 NERVOUSNESS 6 0.0001
963 RASH MACULAR 4 0.0001
964 CARDIAC FAILURE CONGESTIVE 9 0.0001
965 ADVERSE EVENT 10 0.0001
966 OVERDOSE 23 0.0001
967 BLOOD GLUCOSE INCREASED 20 0.0001
968 EYE IRRITATION 6 0.0001
969 INFLAMMATION 5 0.0001
970 ROAD TRAFFIC ACCIDENT 4 0.0001
971 MIGRAINE 9 0.0001
972 HYPOACUSIS 4 0.0001
973 SKIN IRRITATION 4 0.0001
974 CARDIAC DISORDER 8 0.0001
975 ALOPECIA 16 0.0001
976 HOT FLUSH 6 0.0001
977 MALIGNANT NEOPLASM PROGRESSION 8 0.0001
978 ARTHROPATHY 4 0.0001
979 FLATULENCE 4 0.0001
980 VERTIGO 4 0.0001
981 INTENTIONAL OVERDOSE 4 0.0001
982 MYOCARDIAL INFARCTION 10 0.0001
983 BURNING SENSATION 4 0.0001
984 INJURY 4 0.0001
985 DRUG DEPENDENCE 9 0.0001
986 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 10 0.0000
987 INJECTION SITE PAIN 15 0.0000
988 INCORRECT DOSE ADMINISTERED 11 0.0000
989 DRUG WITHDRAWAL SYNDROME 4 0.0000
990 ADVERSE DRUG REACTION 4 0.0000
991 ACNE 3 0.0000
992 INJECTION SITE ERYTHEMA 4 0.0000